HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT05743543

A Pilot Study of SPG Block for PTSD

Interventional studyAges 18–60United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
New YorkSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: May 28, 2019
Recruitment status
Completed
Enrollment listed in the registry
6
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Other
Intervention type
OTHER
Study phase
EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT05743543
Official title
Show the full official title

A Feasibility Study of a Sphenopalatine Ganglion (SPG) Block for Post Traumatic Stress Disorder (PTSD)

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

New York

Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies